Filter
107
Filtered Results: 107
Text search:
Al-mustafa,
M.
Featured
Recommendations
10
New Publications
19
Language
Document type
No document type
38
Studies & Reports
34
Guidelines
18
Manuals
6
Training Material
5
Fact sheets
5
Situation Updates
1
Countries / Regions
Kenya
9
Ethiopia
5
Bangladesh
5
Sierra Leone
4
Somalia
4
Germany
4
Global
4
Liberia
3
Senegal
3
Brazil
3
Guinea
2
Ghana
2
Uganda
2
South Sudan
2
Syria
2
South Africa
2
Argentina
2
Ecuador
2
Middle East and North Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Asia
2
Burkina Faso
1
Mali
1
Guinea-Bissau
1
Haiti
1
Philippines
1
Pakistan
1
Iraq
1
China
1
Rwanda
1
Indonesia
1
Mozambique
1
Sudan
1
Botswana
1
Angola
1
Yemen
1
Western and Central Europe
1
Africa
1
Russia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
33
Women & Child Health
13
Clinical Guidelines
12
Public Health
8
Key Resources
5
Capacity Building
3
Toolboxes
COVID-19
18
HIV
8
Refugee
6
Planetary Health
5
Rapid Response
4
Mental Health
4
TB
4
NCDs
4
Ebola
3
Caregiver
3
NTDs
3
Disability
2
Global Health Education
2
AMR
2
Pharmacy
2
Health Financing Toolbox
2
Cholera
1
Natural Hazards
1
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
A review of current literature and up date data from the field, April 2015.
This report has been published in part in J Hosp Inf. 2015;90:1-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=ebola+nosocomial+shears
Based on WHO South-East Asia Regional Strategy on Autism Spectrum Disorder
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by ...
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by ...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
This guide has been written to provide information and practical advice on developing and delivering local plans an strategies to commission the most effective and efficient older people’s mental health services.Based upon clinical best practice guidance and drawing upon the range of available evi...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The coronavirus disease 2019 (COVID-19) pandemic has created a global and gendered crisis that is compounding existing inequalities and disproportionately affecting girls and women. Emerging evidence from the COVID-19 crisis in 2020 shows school closures, disruptions in essential services and rising...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
11 august 2022, updated version
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
